Insulet
$131.69Change from previous close: +0.69%Absolute change: +$0.90
At a glance
- Revenue growth
- +30.73%
- 2025 vs 2024
- Net income growth
- −40.93%
- 2025 vs 2024
- Net margin
- 9.1%
- 2024: 20.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 3,190 | 3,088 | 2,588 | 2,251 | — |
| Current assets | 1,914 | 1,891 | 1,583 | 1,314 | — |
| Cash and equivalents | 716 | 953 | 704 | 674 | — |
| Short-term investments | — | — | — | — | 0.0 |
| Receivables | 517 | 366 | 360 | 206 | — |
| Inventory | 453 | 430 | 403 | 347 | — |
| Net property, plant and equipment | 819 | 723 | 665 | 600 | — |
| Goodwill | 51.6 | 51.5 | 51.7 | 51.7 | — |
| Other intangible assets | 117 | 98.5 | 98.7 | 75.5 | — |
| Current liabilities | 680 | 528 | 451 | 365 | — |
| Accounts payable | 75.0 | 19.8 | 19.2 | 30.8 | — |
| Long-term debt | 931 | 1,296 | 1,366 | 1,374 | — |
| Total debt | 949 | 1,380 | 1,416 | 1,402 | — |
| Total liabilities | — | 1,876 | 1,856 | 1,775 | 1,493 |
| Total equity (incl. minority) | 1,515 | 1,212 | 733 | 476 | — |
| Retained earnings | 287 | 40.3 | -378 | -584 | — |